Source:
Boston GlobeDrug, ad firms gird as House takes up FDA revamp
By Diedtra Henderson, Globe Staff | June 12, 2007
WASHINGTON -- Pharmaceutical and advertising industry lobbyists who thwarted attempts in the Senate to rein in drug advertising now turn their attention to the House of Representatives, which is scheduled to take up legislation to overhaul the Food and Drug Administration today.
~snip~
Billy Tauzin , chief executive of the Pharmaceutical Research and Manufacturers of America , says such ads provide a valuable service in informing the public about new drugs that could dramatically improve their lives. As a child, Tauzin suffered from osteomyelitis , an acute bone infection caused by bacteria. He was one week from amputation of his right foot .
"My mother read about penicillin in the rural countryside of Louisiana and brought that information to our doctor, who didn't know that penicillin was being used to treat osteomyelitis.
got her information. Put me on a course of penicillin. I have my foot today," Tauzin said.
A "rigid" moratorium doesn't leave room for drugs -- like Gardasil -- that patients should know about and, ultimately, such restrictions hurt patients, he said.
Read more: http://www.boston.com/business/globe/articles/2007/06/12/drug_ad_firms_gird_as_house_takes_up_fda_revamp?mode=PF